Medical/Pharmaceuticals

BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines

MIAMI and ADELAIDE, Australia, April 27, 2023 /PRNewswire/ -- BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a$5.0m AUD grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to fund wor...

2023-04-27 12:15 2143

MGI and South Australian Genomics Centre Introduce DNBSEQ-T7* to Supercharge Genomics Research in Australia

BRISBANE, Australia, April 27, 2023 /PRNewswire/ -- MGI and  South Australian Genomics Centre (SAGC) are proud to announce their joint efforts to advance genomics research inAustralia by introducing the country's first commercial ultra...

2023-04-27 11:45 2393

Antengene to Release Latest Results from the TORCH-2 Trial of mTORC1/2 Inhibitor ATG-008 in Poster Discussion at 2023 ASCO

SHANGHAI and HONG KONG, April 27, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announ...

2023-04-27 08:30 2672

Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

MELBOURNE, Australia, April 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquireVienna-based Dedicaid GmbH (Dedicaid), a spin-off of the Medica...

2023-04-27 06:50 2382

MGI Announces New Customer Experience Center in South Korea with BMS

CHEONAN, South Korea, April 26, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today celebrated the opening of its Customer Experience Center (CEC) inSouth Korea. In partnership with one of the country's leading compan...

2023-04-26 16:00 1916

MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*

SHANGHAI, April 26, 2023 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a global life science tools leader, announced its partnership with Shanghai-based JMDNA Biomedical Technology Co., Ltd. ("JMDNA") for DNBSEQ-T20×2 ("T20"), a sequencer that broke records for its ultra-high throughput and cost-ef...

2023-04-26 15:20 1798

RemeGen Celebrates World Intellectual Property Day 2023

YANTAI, China, April 26, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, is celebrating World Intellectual Property Day 2023 which falls onApril 26, the theme of which mirrors the crit...

2023-04-26 10:00 2357

Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit

MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma inPerth, Australia. The newly cre...

2023-04-26 06:41 1925

Bioved Pharmaceuticals granted a US Patent for its oral, natural plant-based product, Artovid-20® for the treatment of Covid-19

SAN JOSE, Calif., April 26, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets for Covid-19. The Patent titled "Methods and Compounds for Treating Effects of Covid-19 Disease," grants 2...

2023-04-26 03:00 1675

IF YOU, A CHILD IN YOUR CARE, OR ANOTHER LOVED ONE WERE HARMED BY ENDO OR A RELATED COMPANY, INCLUDING PAR OR AMS, OR THEIR PRODUCTS INCLUDING OPIOIDS, RANITIDINE, OR TRANSVAGINAL MESH, YOUR RIGHTS MAY BE AFFECTED BY DEADLINES IN THE ENDO BANKRUPTCY.

The deadline to file a claim in the bankruptcy is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time). The deadline to object to Endo's sale is July 7, 2023, at 4:00 p.m. (prevailing Eastern Time). NEW YORK, April 25, 2023 /PRNewswire/ -- The following is being issued by Kroll Restructuring Adm...

2023-04-25 22:27 1825

ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market

The monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimized visual outcomes. JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved theCT LUCI...

2023-04-25 21:00 1764

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched the contract research organizations industry and, based on its...

2023-04-25 20:30 1559

Wellcome Leap & Temasek Trust Launch US$60M Dynamic Resilience Programme to Extend Health Spans

* Average human life expectancy has doubled from 35 to 70 years over the past century[1], but health spans (number of years spent in good health) have not correspondingly improved[2]   * Multimorbidity (multiple coexisting health conditions) poses an urgent challenge for global health service...

2023-04-25 20:03 1680

Nippon Express (UK) Receives IATA CEIV Pharma Certification for Its Facility in Heathrow Airport Suburb

TOKYO, April 25, 2023 /PRNewswire/ -- Nippon Express (UK) Ltd. (hereinafter "NXUK"), a group company of NIPPON EXPRESS HOLDINGS, INC., has been awarded IATA CEIV Pharma certification*, a quality certificate for pharmaceutical transport established by the International Air Transport Association (I...

2023-04-25 15:00 1888

Biotech firm Gene Solutions: A promising picture for multi-cancer early detection in Southeast Asia

HO CHI MINH CITY, Vietnam, April 25, 2023 /PRNewswire/ -- In January 2023, Vietnam's Medical Genetics Institute & Gene Solutions  published their research paper on Cancer Investigation:Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim r...

2023-04-25 12:00 1893

Mediso launches next generation MRI spectrometer spinScan®

BUDAPEST, Hungary, April 25, 2023 /PRNewswire/ -- Mediso released their next generation MRI spectrometer spinScan® the successor to the previously used console in the nanoScan® MRI product line. The new spectrometer was optimized for MRI applications delivering an ultra-low-...

2023-04-25 09:00 1757

Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer

Seasoned med-tech executive to advance Cynosure's growth and innovation strategy and strengthen the company's position as the medical aesthetics technology leader WESTFORD, Mass., April 24, 2023 /PRNewswire/ -- Cynosure, LLC ("Cynosure" or the "Company"), a leader in medical aesthetics systems a...

2023-04-24 21:01 2053

BMC H-80 series: empowering breathing solutions for breathing and oxygen therapy

BEIJING, April 24, 2023 /PRNewswire/ -- Recently, the H-80 series Respiratory High-Flow Therapy Device has added more comprehensive monitoring indicators for even greater convenience and efficiency to help people in respiratory failure.   April is a crucial month to prioritize the respiratory hea...

2023-04-24 20:00 1610

Daewoong Pharmaceutical Announce Publication of Phase 3 Study of 'Envlo', a New Treatment for Diabetes, in the International SCIE Journal

SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- The research results of Daewoong Pharmaceutical's SGLT-2 inhibitor new drug, 'Envlo', have been internationally acknowledged. On April 4, Daewoong Pharmaceutical (CEO Seng-ho Jeon and Chang-jae Lee) announced that the efficacy and safety evalu...

2023-04-24 14:53 2057

Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901

SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced today the completion of patient dosing in its Phase III Registrational Clinical Trial (CTR20212816) of BBM-H901, a gene therapy for Hemophilia ...

2023-04-24 10:23 2067
1 ... 75767778798081 ... 382